HOUSE DOCKET, NO. 2075 FILED ON: 1/20/2011
HOUSE . . . . . . . . . . . . . . . No. 2051
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Robert F. Fennell
_______________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the passage of the accompanying:
An Act relative to diagnostic screening for prostate cancer. .
_______________
PETITION OF:
Name: | District/Address: |
Robert F. Fennell | 10th Essex |
Christine E. Canavan | 10th Plymouth |
Martha M. Walz | 8th Suffolk |
James J. O'Day | 14th Worcester |
Louis L. Kafka | 8th Norfolk |
Kevin G. Honan | 17th Suffolk |
Brian M. Ashe | 2nd Hampden |
Frank I. Smizik | 15th Norfolk |
Sal N. DiDomenico | Middlesex, Suffolk, and Essex |
Cory Atkins | 14th Middlesex |
Carlo Basile | 1st Suffolk |
Walter F. Timilty | 7th Norfolk |
HOUSE DOCKET, NO. 2075 FILED ON: 1/20/2011
HOUSE . . . . . . . . . . . . . . . No. 2051
By Mr. Fennell of Lynn, a petition (accompanied by bill, House, No. 2051) of Robert F. Fennell and others that health insurance providers be required to include coverage for diagnostic screening for prostate cancer. Financial Services. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE
HOUSE
, NO. 898 OF 2009-2010.]
The Commonwealth of Massachusetts
An Act relative to diagnostic screening for prostate cancer. .
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Notwithstanding any general or special law to the contrary, every contract which provides coverage for hospital, surgical or medical care shall provide the following coverage for diagnostic screening for prostatic cancer:(i) upon the recommendation of a physician, medically recognized diagnostic testing including, but not limited to, a digital rectal examination, transrectal ultrasonography and prostate-specific antigen test at any age for covered persons having a prior history of prostate cancer; and (ii) an annual medically recognized diagnostic examination including, but not limited to, a digital rectal examination, trans-rectal ultrasonography and a prostate-specific antigen test for all men aged forty and over.
